Beverley M. Shields

38.4k citations

128 papers · 7.3k indexed · 3 hit papers · h-index 50

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Thyroid Disorders and Treatments
Genetics top 0.2%
- Diabetes and associated disorders
- Genetic Associations and Epidemiology

Papers in

Endocrinology, Diabetes and Metabolism 94
- Diabetes Management and Research 57
- Diabetes Treatment and Management 43
- Thyroid Disorders and Treatments 9
Genetics 55
- Diabetes and associated disorders 49

Co-authors: Andrew T. Hattersley Sian Ellard Timothy J. McDonald Angus G. Jones Bridget Knight Maggie Shepherd Kevin Colclough Michael N. Weedon
Journals: Diabetes Care (19 papers)Diabetologia (13 papers)Diabetic Medicine (11 papers)Diabetes (8 papers)BMJ Open (8 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Beverley M. Shields

128 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data 2019 · 282 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 The Lancet Diabetes & Endocrinology
2017 The Lancet Diabetes & Endocrinology
2010 Diabetologia

Peers

Countries citing papers authored by Beverley M. Shields

Since Specialization

Citations

This map shows the geographic impact of Beverley M. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverley M. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverley M. Shields more than expected).

Fields of papers citing papers by Beverley M. Shields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverley M. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverley M. Shields. The network helps show where Beverley M. Shields may publish in the future.

Co-authors

The 25 scholars most cited alongside Beverley M. Shields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beverley M. Shields Line = papers co-authored together Beverley M. Shields links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection Diabetologia ·Prosper Msambazya, Katherine Young, М. Суханова, Andrew McGovern, Beverley M. Shields, Andrew T. Hattersley, Angus G. Jones, Ewan R. Pearson, Coralie Bingham, Richard A. Oram, John Dennis	2025	1
2	Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young BMC Medical Research Methodology ·大次郎北河, Timothy J. McDonald, Kashyap Patel, Ewan R. Pearson, Andrew T. Hattersley, Beverley M. Shields, Trevelyan J. McKinley	2024	2
3	Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study BMJ Open ·М. Суханова, Katherine Young, Nicholas J. Thomas, Marziyeh Asadian, Lakhwinder, Bilal A. Mateen, Robert Challen, Sebastian J. Vollmer, Beverley M. Shields, Andrew McGovern, John Dennis	2024	6
4	Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach Diabetologia ·Marie-Hélène Corbiau, L. I. Pankrutskaya, Nicholas J. Thomas, М. Суханова, Robert Challen, Angus G. Jones, Andrew T. Hattersley, Ewan R. Pearson, Beverley M. Shields, Jack Bowden, John Dennis, Andrew McGovern	2024	9
5	Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Diabetologia ·大次郎北河, Katherine Young, Anand Thakarakkattil Narayanan Nair, М. Суханова, Andrew McGovern, Eram Haider, J. A. Gunst, Louise A. Donnelly, Bilal A. Mateen, Naveed Sattar, Rury R. Holman, Jack Bowden, Andrew T. Hattersley, Ewan R. Pearson, Angus G. Jones, Beverley M. Shields, Trevelyan J. McKinley, John Dennis	2024	12
6	Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics The Journal of Clinical Endocrinology & Metabolism ·Sian Grace, Jack Bowden, Helen C. Walkey, HEATHER FREAMO, Shivani Misra, Beverley M. Shields, Trevelyan J. McKinley, Nick Oliver, Timothy J. McDonald, Desmond G. Johnston, Angus G. Jones, Kashyap Patel	2022	8
7	Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study Nature Medicine ·Beverley M. Shields, John Dennis, Brissy Catherine, Fiona C Warren, William Henley, Andrew Farmer, Naveed Sattar, Rury R. Holman, Angus G. Jones, Ewan R. Pearson, Andrew T. Hattersley, (unknown)	2022	27
8	The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis Diabetologia ·Katherine Young, Andrew McGovern, Inês Barroso, Andrew T. Hattersley, Angus G. Jones, Beverley M. Shields, Nicholas J. Thomas, John Dennis	2022	4
9	Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study Nature Medicine ·Beverley M. Shields, Brissy Catherine, Maggie Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury R. Holman, Ewan R. Pearson, Andrew T. Hattersley	2022	8
10	Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11\n Europe PMC (PubMed Central) ·Paul Eaton, Daphne Yau, C.Y. Kim, Thomas W. Laver, Jayne Houghton, Beverley M. Shields, Sarah E. Flanagan, Kashyap Patel	2021	7
11	Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes Diabetes Care ·Angus G. Jones, Timothy J. McDonald, Beverley M. Shields, William Hagopian, Andrew T. Hattersley	2021	56
12	Investigating the causal effect of maternal vitamin B12 and folate levels on offspring birthweight International Journal of Epidemiology ·Gunn-Helen Moen, Robin N. Beaumont, Niels Grarup, Christine Sommer, Beverley M. Shields, Debbie A. Lawlor, Rachel M. Freathy, David M. Evans, Nicole M. Warrington	2020	6
13	Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation BMJ Open Diabetes Research & Care ·Andrew McGovern, Michael A. Hogg, Beverley M. Shields, Naveed Sattar, Rury R. Holman, Ewan R. Pearson, Andrew T. Hattersley, Angus G. Jones, John Dennis	2020	62
14	Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017 Diabetes Obesity and Metabolism ·John Dennis, William Henley, Andrew McGovern, Andrew Farmer, Naveed Sattar, Rury R. Holman, Ewan R. Pearson, Andrew T. Hattersley, Beverley M. Shields, Angus G. Jones	2019	68
15	Identifying routine clinical predictors of non‐adherence to second‐line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care database Diabetes Obesity and Metabolism ·Beverley M. Shields, Andrew T. Hattersley, Andrew Farmer	2019	9
16	Fetal Genotype and Maternal Glucose Have Independent and Additive Effects on Birth Weight Diabetes ·Alice E. Hughes, Michael Nodzenski, Robin N. Beaumont, Octavious Talbot, Beverley M. Shields, Denise Scholtens, Bridget Knight, William L. Lowe, Andrew T. Hattersley, Rachel M. Freathy	2018	33
17	A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy Diabetes Care ·L. Landi, Timothy J. McDonald, Femke Rutters, Louise A. Donnelly, Andrew T. Hattersley, Richard A. Oram, (unknown), Amber A. van der Heijden, Fiona Carr, Petra J. M. Elders, Michael N. Weedon, Roderick C. Slieker, Leen M. ‘t Hart, Ewan R. Pearson, Beverley M. Shields, Angus G. Jones	2018	38
18	C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase Diabetes Care ·Beverley M. Shields, Timothy J. McDonald, Richard A. Oram, Anita Hill, Michelle Hudson, Pia Leete, Ewan R. Pearson, Sarah J. Richardson, Noel G. Morgan, Andrew T. Hattersley, Bart O. Roep, Timothy Tree, S. Hammersley, Dominic Macqueen	2018	75
19	Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy The Journal of Clinical Endocrinology & Metabolism ·Beverley M. Shields, Rachel M. Freathy, Bridget Knight, Anita Hill, Michael N. Weedon, Timothy M. Frayling, Andrew T. Hattersley, Bijay Vaidya	2009	23
20	Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding? The Journal of Clinical Endocrinology & Metabolism ·Bijay Vaidya, Sony Anthony, Mary Bilous, Beverley M. Shields, John Drury, F. Sri Lestariyati, Rudy Bilous	2006	301

About Beverley M. Shields

Beverley M. Shields is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Family Practice, Surgery and Obstetrics and Gynecology, having authored 128 papers that have together received 7.3k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (61 papers), Diabetes Management and Research (57 papers), Diabetes and associated disorders (49 papers), Diabetes Treatment and Management (43 papers), Metabolism, Diabetes, and Cancer (16 papers), Birth, Development, and Health (13 papers), Thyroid Disorders and Treatments (9 papers) and Gestational Diabetes Research and Management (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.2k citations), Genetics (4.1k citations), Surgery (4.0k citations), Obstetrics and Gynecology (544 citations) and Family Practice (76 citations). Beverley M. Shields has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Andrew T. Hattersley, Sian Ellard, Timothy J. McDonald, Angus G. Jones, Bridget Knight, Maggie Shepherd, Kevin Colclough, Michael N. Weedon, Richard A. Oram and Anita Hill. Their work appears in journals such as Diabetes Care, Diabetologia, Diabetic Medicine, Diabetes and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact